Catalyst Biosciences Inc (NASDAQ:CBIO)

6.10
Delayed Data
As of 4:00pm ET
 -0.12 / -1.93%
Today’s Change
3.43
Today|||52-Week Range
8.22
-3.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$185.6M

Company Description

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

Contact Information

Catalyst Biosciences, Inc.
611 Gateway Boulevard
South San Francisco California 94080
P:(650) 871-0761
Investor Relations:

Employees

Shareholders

Individual stakeholders6.38%
Other institutional39.18%
Mutual fund holders11.42%

Top Executives

Nassim UsmanPresident, Chief Executive Officer & Director
Clinton MusilChief Financial Officer
Howard LevyChief Medical Officer
Andrew HetheringtonSenior Vice President-Technical Operations
Linda NeumanVice President-Clinical Development